Evidence map›Paper›PMID 40036975›Full record

ArticleBioinformatics (Oxford, England)2025

EPIPDLF: a pretrained deep learning framework for predicting enhancer-promoter interactions.

Zhichao Xiao, Yan Li, Yijie Ding, Liang Yu

Abstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. EPIFBMC: A New Model for Enhancer-Promoter Interaction Prediction.International journal of molecular sciences · 2025
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Zhichao XiaoSchool of Computer Science and Technology, Xidian University, Xi'an 710075, China.
Yan LiSchool of Management, Xi'an Polytechnic University, Xi'an 710075, China.
Yijie DingYangtze Delta Region Institute (Quzhou), University of Electronic Science and Technology of China, Quzhou 324000, China.ORCID 0000-0003-2911-7643
Liang YuSchool of Computer Science and Technology, Xidian University, Xi'an 710075, China.ORCID 0000-0002-8351-3332

Funding

Municipal Government of Quzhou 2023D038National Natural Science Foundation of China 62472344Xidian University Specially Funded Project for Interdisciplinary Exploration TZJH2024027Zhejiang Provincial Natural Science Foundation of China LY23F020003
6 · The paper itself

Abstract

motivationEnhancers and promoters, as regulatory DNA elements, play pivotal roles in gene expression, homeostasis, and disease development across various biological processes. With advancing research, it has been uncovered that distal enhancers may engage with nearby promoters to modulate the expression of target genes. This discovery holds significant implications for deepening our comprehension of various biological mechanisms. In recent years, numerous high-throughput wet-lab techniques have been created to detect possible interactions between enhancers and promoters. However, these experimental methods are often time-intensive and costly.

resultsTo tackle this issue, we have created an innovative deep learning approach, EPIPDLF, which utilizes advanced deep learning techniques to predict EPIs based solely on genomic sequences in an interpretable manner. Comparative evaluations across six benchmark datasets demonstrate that EPIPDLF consistently exhibits superior performance in EPI prediction. Additionally, by incorporating interpretable analysis mechanisms, our model enables the elucidation of learned features, aiding in the identification and biological analysis of important sequences. AVAILABILITY AND IMPLEMENTATION: The source code and data are available at: https://github.com/xzc196/EPIPDLF.

Indexed as

Computational BiologyDeep LearningEnhancer Elements, GeneticPromoter Regions, GeneticSoftwareHumans

Identifiers

PMID40036975
PMCPMC12057809

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.